Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Passarelli

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Frontiers in Immunology|October 19, 2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With NivolumabMaria Grazia Narducci, Anna Tosi, Alessandra Frezzolini, et al.
Recenti Progressi in Medicina|December 28, 2020
[The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.]Luca Fania, Roberto Morese, Giovanni Di Lella, et al.
Journal of the American Academy of Dermatology|March 3, 2022
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter studyAdele Salemme, Luca Fania, Alessandra Scarabello, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Frontiers in Immunology|October 19, 2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With NivolumabMaria Grazia Narducci, Anna Tosi, Alessandra Frezzolini, et al.
Recenti Progressi in Medicina|December 28, 2020
[The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.]Luca Fania, Roberto Morese, Giovanni Di Lella, et al.
Journal of the American Academy of Dermatology|March 3, 2022
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter studyAdele Salemme, Luca Fania, Alessandra Scarabello, et al.
Pageof 6